Gennex Lab Peer Comparison

BSE: 531739

₹12.91

₹-0.05 (-0.39%)

As on 28-Aug-2026IST

Market cap

₹314 Cr

Revenue (TTM)

₹183 Cr

P/E Ratio

16.2

P/B Ratio

1.4

Div. Yield

0 %

Edit

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Market cap (₹ Cr)	314	21,501	19,125	18,253	17,766
Revenue (₹ Cr)	183	2,570	2,287	3,230	2,432
Net Profit (₹ Cr)	20.63	735.15	678.07	666.92	169.62
Net Margin (%)	11.07	26.88	28.10	20.60	6.90
RoE (%)	9.14	19.16	19.73	18.75	20.76
Price to Earnings	16.17	29.25	28.74	28.35	104.74
Price-To-Book	1.38	4.88	5.08	4.51	19.65

Income Statement (₹ Cr)

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Operating Revenue	183.06	2,569.77	2,287.33	3,229.67	2,432.06
Total Income	186.38	2,735.39	2,413.29	3,237.12	2,458.54
Total Expenditure	156.66	1,628.14	1,490.75	2,090.06	2,202.20
EBITDA	26.39	941.63	796.58	1,139.61	229.86
Depreciation	2.71	57.58	78.10	281.06	17.24
EBIT	23.68	884.05	718.48	858.55	212.62
Interest	4.12	7.69	0.88	190.64	5.72
Other Income	3.33	165.62	125.96	7.45	26.48
Exceptional Items	-0.60	-49.16	0.00	-17.24	-5.13
Profit before Tax	22.29	992.82	843.56	658.12	228.25
Provision for Tax	1.66	257.67	165.49	-8.80	58.63
Profit after Tax	20.63	735.15	678.07	666.92	169.62

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Shareholder's Funds	222.52	4,202.90	3,586.42	3,902.67	872.79
Minority Interest	-1.23	0.00	-12.71	-21.81	0.00
Non-Current Liabilities	43.44	91.50	28.74	1,392.75	134.50
Current Liabilities	72.40	627.48	385.94	2,077.10	981.81
Total Liabilities	256.04	4,911.11	3,207.85	6,862.28	1,879.19

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Non-Current Assets	74.07	770.28	1,291.22	5,617.77	42.47
Current Assets	264.66	3,803.22	2,585.66	1,539.85	1,739.93
Total Assets	256.04	4,911.11	3,207.85	6,862.28	1,879.19
Total Debt*	24.28	2.50	0.55	2,421.66	0.00
Net Current Assets	192.26	3,175.74	2,199.72	-537.25	758.12
Contingent Liabilities	0.98	363.79	0.64	64.29	98.41

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Cash From Operating Activities	-10.80	659.75	432.37	1,065.01	65.36
Cash Flow from Investing Activities	0.82	-71.34	-334.73	-79.97	30.80
Cash from Financing Activities	4.57	-205.34	-38.32	-881.32	-65.59
Net Cash Inflow / Outflow	-5.41	383.07	59.32	103.72	30.57

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
ROCE (%)	12.49	26.21	26.22	13.59	21.29
ROE (%)	9.14	19.16	19.73	18.75	20.76
ROA (%)	6.82	14.95	18.69	9.26	9.67
EBIT Margin (%)	12.94	34.40	31.41	26.58	8.74
Net Margin (%)	11.07	26.88	28.10	20.60	6.90
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Revenue Growth (%)	23.78	10.69	15.01	9.59	31.10
EBIT Growth (%)	18.82	24.14	18.45	16.84	-12.99
Net Profit Growth (%)	11.37	-9.09	19.61	62.68	-7.49
EPS Growth (%)	6.03	14.40	17.73	67.41	-18.33
Book Value Growth (%)	9.90	17.30	23.77	10.19	7.70

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Price / Earnings	15.75	27.87	28.74	27.66	102.37
Price / Book Value	1.38	4.88	5.08	4.51	19.65
Dividend Yield (%)	0.00	1.60	0.16	0.55	0.51
EV/EBITDA	10.70	19.53	22.88	17.94	75.34
Market Cap (₹ Cr)	274.07	18,318.10	15,219.80	19,292.77	21,515.93

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Debt to Equity	0.00	0.00	0.00	0.24	0.00
Short term debt to equity ratio	0.05	0.00	0.00	0.14	--
Current Ratio	3.66	6.06	6.70	0.74	1.77
Quick Ratio	2.91	5.31	5.59	0.53	0.73
Interest Coverage	6.41	130.11	959.59	4.45	40.90

	Gennex Lab	Pfizer	Caplin Point Lab	Eris Lifesciences	Astrazeneca Pharma
Debtors to sales (%)	23.79	7.07	36.10	21.07	8.79
Asset Turnover	0.61	0.52	0.63	0.45	1.39
Receivable days	37.35	29.10	110.70	54.07	35.81
Inventory Days	71.39	69.53	65.86	32.16	82.25
Payable days	53.27	76.77	105.88	140.91	124.39
Cash Conversion Cycle	55.46	21.86	70.68	-54.68	-6.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.